### **Clinical Guideline Summary: Intramuscular Methotrexate for Ectopic Pregnancy & Persistent Gestational Trophoblastic Disease**  

**Purpose:**  
Ensure safe administration of IM Methotrexate for ectopic pregnancy or persistent gestational trophoblastic disease (PGTD).  

**Key Indications:**  
- **Ectopic Pregnancy:** Dose = 50 mg/m² (BSA-based). Strict patient selection criteria apply.  
- **PGTD:** Chemotherapy for molar pregnancies with ongoing monitoring.  

**Contraindications:**  
- Allergy to Methotrexate  
- Significant pain/bleeding (ectopic)  
- Abnormal renal/liver function  

**Pre-Administration Checks:**  
- Informed consent  
- Valid, legible prescription (patient details, dose, route, prescriber signature)  
- Normal baseline bloods (renal/liver function)  

**Administration Steps:**  
1. **Site Prep:** Gluteus maximus (lateral position), assess for lesions/infection.  
2. **Technique:** Z-track method, aspirate before injection, slow administration (1 mL/10 sec).  
3. **Post-Injection:** No massage, apply plaster if needed.  

**Safety & Disposal:**  
- **Staff:** Avoid administration if pregnant.  
- **Waste:** Cytotoxic sharps bin for needles/spillage.  
- **Spill Kit Use:** Blot, clean outward-in, detergent wash, cytotoxic waste disposal.  

**Monitoring & Competency:**  
- Staff must complete training and competency assessment.  
- Incidents and adherence to SOP are audited.  

**Documentation:**  
- Record administration in charts.  
- Competency forms stored in practitioner’s folder.  

**Equipment Checklist:**  
- Prescription, Methotrexate, 21G/23G needle, cytotoxic waste bin, spill kit.